239 related articles for article (PubMed ID: 10203153)
1. Increased tissue-type plasminogen activator antigen release is not accompanied by increased systemic fibrinolytic activity in severe neonatal respiratory distress syndrome.
Brus F; Oetomo SB; Schieving J; Groothuis E; Okken A; van Oeveren W
Pediatr Res; 1999 Apr; 45(4 Pt 1):588-94. PubMed ID: 10203153
[TBL] [Abstract][Full Text] [Related]
2. Activation of the plasma clotting, fibrinolytic, and kinin-kallikrein system in preterm infants with severe idiopathic respiratory distress syndrome.
Brus F; van Oeveren W; Okken A; Oetomo SB
Pediatr Res; 1994 Nov; 36(5):647-53. PubMed ID: 7877886
[TBL] [Abstract][Full Text] [Related]
3. Disease severity is correlated with plasma clotting and fibrinolytic and kinin-kallikrein activity in neonatal respiratory distress syndrome.
Brus F; Van Oeveren W; Okken A; Oetomo SB
Pediatr Res; 1997 Jan; 41(1):120-7. PubMed ID: 8979300
[TBL] [Abstract][Full Text] [Related]
4. Thrombin/antithrombin III complex formation in the neonatal respiratory distress syndrome.
Schmidt B; Vegh P; Weitz J; Johnston M; Caco C; Roberts R
Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):767-70. PubMed ID: 1554199
[TBL] [Abstract][Full Text] [Related]
5. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.
Viscardi RM; Broderick K; Sun CC; Yale-Loehr AJ; Hessamfar A; Taciak V; Burke KC; Koenig KB; Idell S
Am Rev Respir Dis; 1992 Aug; 146(2):492-9. PubMed ID: 1489146
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic system in early respiratory distress syndrome: reduced fibrinolytic state?
Yurdakök M; Yiğit S
Turk J Pediatr; 1999; 41(4):489-93. PubMed ID: 10770117
[TBL] [Abstract][Full Text] [Related]
7. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
Mehta P; Parker RI
J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
[TBL] [Abstract][Full Text] [Related]
8. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
Cederqvist K; Sirén V; Petäjä J; Vaheri A; Haglund C; Andersson S
Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
[TBL] [Abstract][Full Text] [Related]
9. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
10. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
[TBL] [Abstract][Full Text] [Related]
11. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
12. Blood coagulation and fibrinolysis during normal pregnancy.
van Wersch JW; Ubachs JM
Eur J Clin Chem Clin Biochem; 1991 Jan; 29(1):45-50. PubMed ID: 1904779
[TBL] [Abstract][Full Text] [Related]
13. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
14. Activation of the fibrinolytic system in patients with fulminant liver failure.
Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis system in patients with bronchial asthma.
Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease.
Pedersen OD; Gram J; Jespersen J
Thromb Haemost; 1995 May; 73(5):835-40. PubMed ID: 7482412
[TBL] [Abstract][Full Text] [Related]
17. Activation of fibrinolytic pathways is associated with duration of supraceliac aortic cross-clamping.
Haithcock BE; Shepard AD; Raman SB; Conrad MF; Pandurangi K; Fanous NH
J Vasc Surg; 2004 Aug; 40(2):325-33. PubMed ID: 15297829
[TBL] [Abstract][Full Text] [Related]
18. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
[TBL] [Abstract][Full Text] [Related]
19. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
20. Thrombin activatable fibrinolysis inhibitor activity, thrombin-antithrombin complex and D-dimer levels in preterm neonates with early respiratory distress syndrome.
Gursoy T; Tekinalp G; Yurdakok M; Ozcebe O; Korkmaz A; Gurgey A
Am J Hematol; 2008 Jan; 83(1):50-3. PubMed ID: 17654683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
